Walsh Deina H 4
4 · Bone Biologics Corp · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Walsh Deina H
Chief Financial Officer
Transactions
- Award
Employee Stock Option
2024-01-17+12,500→ 12,500 totalExercise: $3.61From: 2024-01-17Exp: 2026-01-17→ Common Stock (12,500 underlying)
Holdings
- 78
Employee Stock Option
Exercise: $57.60Exp: 2025-01-25→ Common Stock (78 underlying) - 1,875
Common Stock
Footnotes (2)
- [F1]This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately.
- [F2]This option is fully vested as of the date of this report.